Atherosclerosis
Researchers' data advance atherosclerosis research
Published in Obesity and Diabetes Week, May 16th, 2005
Study 1: Recent research from the United States has documented the effects of silencing leukocyte-type lipoxygenase using short interfering RNAs.
"The leukocyte-type 12/15-lipoxygenase (12/15-LO) has been implicated in the pathogenesis of atherosclerosis, hypertension, and diabetes. 12/15-LO and its products are associated with LDL oxidation, cellular growth, migration, adhesion, and inflammatory gene expression in monocytes/macrophages, endothelial cells, and vascular smooth muscle cells (VSMCs).
"Our objective, therefore, was to develop novel...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Mice lacking PTEN in adipose tissue are resistance to diabetes - Insulin Resistance
Linoleic acid reduces insulin resistance in obese/diabetic mice - Metabolic Syndrome
Adipocyte glyceroneogenesis involved in metabolic syndrome - Metabolic Syndrome
PPAR-delta agonists developed to treat metabolic syndrome - Obesity and Diabetes
ApoC-III bound to lipoproteins increases with insulin resistance - Amyotrophic Lateral Sclerosis
Company meets with FDA to discuss arimoclomol trial for ALS - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
